Votellaz Prolonged-release Tablet

Sodium valproate

500 mg

AUROBINDO PHARMA LIMITED

Pack size	30's Pack
Dispensing mode
Source
Agent
Retail Price	1.55 AED

Indications

Votellaz Prolonged-release Tablet is used for: This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex sodium is also used to treat the manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Sodium valproate :

Mechanism of Action

Although the mechanism of action of valproate is not fully understood, it has recently been shown to protect against a seizure-induced reduction in phosphatidylinositol (3,4,5)-trisphosphate (pip3) as a potential therapeutic mechanism. In addition, its anticonvulsant effect has been attributed to the blockade of voltage-dependent sodium channels and increased brain levels of gamma-aminobutyric acid (gaba). The gabaergic effect is also believed to contribute towards the anti-manic properties of valproate

Note

Votellaz 500 mg Prolonged-release Tablet manufactured by AUROBINDO PHARMA LIMITED. Its generic name is Sodium valproate. Votellaz is availble in Saudi Arabia. Farmaco SA drug index information on Votellaz Prolonged-release Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Sodium valproate :

Syrup

VALOPRA ^{57.64 mg/ml}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Solution

VALOPRA ^{200 mg/ml}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Powder and Solvent for Solution for Injection

DEPAKINE ^{100 mg/ml}

ALLERGAN INC.

Solution for Injection/Infusion

VALPOHARDT ^{100 mg/ml}

ALFA INTES INDUSTRIA TERAPEUTICA SPLENDORE S.R.L

Syrup

DEPAKINE ^{57.64 mg/ml}

BEXIMCO PHARMACEUTICALS LIMITED